Endonovo Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ENDV for the last quarter is 5.98 k USD, and it's 293.55% higher compared to the previous quarter. The net income of Q4 23 is -1.60 M USD.